| Lung Cancer |
1 |
1 |
| Non-Small Cell Lung Cancer |
0 |
0.99 |
| Biomarker |
0 |
0.72 |
| Biologic Therapy |
0 |
0.63 |
| Genomic Medicine |
0 |
0.43 |
| Targeted Cancer Therapy |
0 |
0.36 |
| Cancer |
0 |
0.31 |
| Small Cell Lung Cancer |
0 |
0.28 |
| Squamous Cell Carcinoma |
0 |
0.25 |
| Tumor |
0 |
0.18 |
| Electronic Health Record (EHR) |
0 |
0.17 |
| Europe |
0 |
0.14 |
| Lung |
0 |
0.14 |
| Spain |
0 |
0.14 |
| Hospital |
0 |
0.09 |
| Melanoma |
0 |
0.07 |
| Anaplastic Lymphoma Kinase |
0 |
0.04 |
| BRAF |
0 |
0.04 |
| Clinical Guidelines |
0 |
0.04 |
| Colorado |
0 |
0.04 |
| DNA Sequencing |
0 |
0.04 |
| Epidermal Growth Factor Receptor |
0 |
0.04 |
| Grant |
0 |
0.04 |
| Histology |
0 |
0.04 |
| Immunotherapy |
0 |
0.04 |
| KRAS |
0 |
0.04 |
| Medical Innovations |
0 |
0.04 |
| Virginia |
0 |
0.04 |